Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 67(Granted Patents)

Location History:

San Francisco, CA (US) (2020)
Oakland, CA (US) (2005 - 2023)

Company Filing History:

24 out of 15,458

University of California

patents

5 out of 1,929

University of South Florida

patents

4 out of 523

Pharmacia & Upjohn Company

patents

4. 3 out of 3

Leidos Biomedical Research, Inc.

Advanced Genetic Systems, Inc.

patent

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

31 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12139470 - Trioxolane agents (2024-11-12),

2. 11541044 - K-Ras modulators (2023-01-03),

3. 11358940 - K-Ras modulators (2022-06-14),

4. 11220477 - Modulators of the eIF2alpha pathway (2022-01-11),

5. 11072594 - Trioxolane agents (2021-07-27),

6. 11014955 - Cyclic peroxides as prodrugs for selective delivery of agents (2021-05-25),

7. 10864222 - Beta-lactamase inhibitors, formulations, and uses thereof (2020-12-15),

8. 10857140 - K-Ras modulators (2020-12-08),

9. 10688080 - Compositions, methods of use, and methods of treatment (2020-06-23),

10. 10662215 - Cyclic peroxides as prodrugs for selective delivery of agents (2020-05-26),

11. 10604493 - Compositions, methods of use, and methods of treatment (2020-03-31),

12. 10543221 - Beta-lactamase inhibitors, formulations, and uses thereof (2020-01-28),

13. 10343981 - Modulators of the eIF2alpha pathway (2019-07-09),

14. 10287312 - Cyclic peroxides as prodrugs for selective delivery of agents (2019-05-14),

15. 10154992 - Compounds and methods for treating HIV infection (2018-12-18),

Title: Adam Renslo: Innovator and Researcher in Disease Treatment

Introduction

Adam Renslo, based in Oakland, CA, is a distinguished inventor and researcher with an impressive portfolio of 31 patents. His work focuses primarily on innovative compounds and methods aimed at treating and detecting various diseases, particularly in the realm of cancer research.

Latest Patents

Among Adam's latest groundbreaking patents are trioxolane agents, which disclose trioxolane compounds and methods for their application in treating and detecting diseases. Additionally, he has developed K-Ras modulators that provide novel methods and compounds for inhibiting K-Ras, a crucial focus in cancer therapy.

Career Highlights

Adam has made significant contributions to the field of biomedical research, having worked with notable institutions such as the University of California and the University of South Florida. His role in these institutions has facilitated pivotal advancements in the development of therapeutic agents aimed at combating serious health conditions.

Collaborations

Throughout his career, Adam Renslo has collaborated with esteemed colleagues, including Gary W. Luehr and Erica M. W. Lauterwasser. These partnerships have fostered a dynamic environment for innovation and research, enhancing the impact of their work on the medical community.

Conclusion

With his extensive portfolio of patents and collaborative efforts in research, Adam Renslo continues to be a vital figure in the field of medical innovation. His dedication to improving disease treatment and diagnosis paves the way for future advancements that hold the promise of better health outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.